Gastrointestinal Devices Product Portfolio and Pipeline | United States | 2017-2023 | MedFolio

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Pages: 161
  • Published Date: 10/1/2016
  • Type: MedFolio

Product Description

The U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. The largest segment in the total GI endoscopic device market was the GI flexible endoscope segment. This segment represented approximately 24.5% of the total market in 2016. The relatively large size of this segment is due to a combination of relatively high average selling price (ASP) coupled with relatively short life-span of five years, resulting in constant renewal of the equipment. One of the main drivers in this market is the growth in the procedure numbers, such as colonoscopy and therapeutic ERCP. Colonoscopy has become a gold-standard in the colorectal cancer screening program, with more than 18 million procedures performed annually. A lot of devices discussed in this report are used in conjunction with the each other, thus having a multiplication effect on the size of the market with each extra procedure performed.
 

FREE Sample Report



The "US Market Report Suite for Gastrointestinal Endoscopic Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Boston Scientific
Olympus
Medtronic
Cook Medical
Halyard
Medline
Pentax
ConMed
Fujinon
Moog
C. R. Bard
Endogastric
GE Healthcare
Others include: Alcor Scientific, Applied Medical Technologies, BARD, C2 Therapeutics, Capso Vision, ConMed, CSA Medical, Endochoice, ERBE, Genii, GI Supply, Hobbs Medical, Intromedic, Mederi, Medigus, Medivators, Medline, Merit Endotek, Micro-tech Endoscopy, Mobile Instruments, Moog, Northfield Instruments, Philips, Prezio, MedService International, Rendoscopy, Siemens, Steris, Taewoon Medical, Telemed Systems, TeraREcon, Torax, US Endoscopy, Viatronix, Vital Images, and others.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.

  • 2017
  • 2013-2023
  • United States
  • 10/1/2016
  • 161
  • MedFolio
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library